NovaBay Pharmaceuticals, Inc. (AMEX:NBY)
| CAPS Rating |
|
|---|---|
| Open | $1.46 |
| Previous Close | $1.43 |
| Daily Range | $1.38 - $1.46 |
| 52-Week Range | $0.67 - $2.48 |
| Market Cap | $39.67M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 61,676 |
| Average Daily Volume | 0 |
NBY
VS S&P 500 (SPY)
How do you think NBY will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
NBY Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
NBY News and Commentary
- Avoid This Drug Stock – The Motley Fool
- Acient Protein is Potent Antibiotic – Blog at The Motley Fool
- Hello Delisting! – Blog at The Motley Fool
- This Stock is Cliffdiving – Blog at The Motley Fool
- NovaBay Opportunity Emerging – Blog at The Motley Fool
- IBM's Tiny Technology Rips Up Drug-Resistant Germ Cells in Early Research – Blog at The Motley Fool
- BlacknGold Pharma Blogs - NBY – Blog at The Motley Fool
- BlacknGold Pharma Blogs – Blog at The Motley Fool
Related News and Articles
- Modified Study, Same Bloody Results – The Motley Fool
- Buy, Sell, or Hold: Ariad Pharmaceuticals – The Motley Fool
- Why Did My Stock Just Die? – The Motley Fool
- Merck Investors Can Sleep Easier (Not Easy) – The Motley Fool
- Is This Situation Special Enough? – The Motley Fool
- Investments for Income Lovers – The Motley Fool
- The Highest-Yielding Dow Stocks – The Motley Fool
- Dividend Stocks You Need to Watch Today – The Motley Fool
- 3 Stocks on Our Radar – The Motley Fool
- Curing Diseases Makes For a Bad Business Model – The Motley Fool
RSS Headlines
Fool UK
